MetaCap

Travere Therapeutics (TVTX) News

NASDAQ: TVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

47.00-1.30 (-2.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TVTX news summary

We found 9 recent headlines mentioning Travere Therapeutics (TVTX): 0 in the past week and 6 in the past 30 days, most often from Nasdaq, Seeking Alpha, Business Wire. For price context, TVTX is down 2.69% at $47.00. The most recent story, "Why is Travere Therapeutics stock sliding today?", was published by Investing.com on Nov 3, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Travere Therapeutics headlines

Stocks mentioned alongside TVTX

Compare TVTX